Last-Resort CAR-T therapy made available for desperate myeloma patients
Disease control
AVAILABLE
This program offers a special version of the CAR-T therapy cilta-cel to people with multiple myeloma who have run out of standard options. The treatment is made from the patient's own immune cells and aims to control the cancer, but it is not a cure and may require ongoing care. …
Sponsor: Janssen Scientific Affairs, LLC • Aim: Disease control
Last updated May 08, 2026 12:03 UTC